Investigations to Identify the Underlying Cause of SIADH
Your patient requires at minimum a chest CT scan to evaluate for malignancy, as lung cancer (particularly small cell lung cancer) is the most common malignant cause of SIADH, accounting for 10-45% of SCLC cases producing ADH. 1
Systematic Diagnostic Workup
Essential Investigations
Imaging:
- Chest CT scan (not just radiograph) - This is the single most important investigation, as pulmonary malignancies and lung diseases are leading causes of SIADH 1, 2
- Head CT or MRI if CNS pathology suspected (trauma, infection, hemorrhage, tumors)
Laboratory Tests:
- Thyroid function tests (TSH, free T4) - to exclude hypothyroidism 1
- Morning cortisol or ACTH stimulation test - to exclude adrenal insufficiency 1
- Review all medications thoroughly - drugs are the most frequent cause of SIADH, particularly antidepressants, antiepileptics, and chemotherapy agents 2, 3, 4
Etiologic Categories to Consider
The four main groups of SIADH causes are 2, 5:
- Malignancies - especially SCLC, but also squamous cell carcinoma and adenocarcinoma of lung
- Medications - most common overall cause
- CNS disorders - trauma, infection, hemorrhage, tumors
- Pulmonary diseases - pneumonia, tuberculosis, other infections
Additional Confirmatory Tests
- Serum uric acid - should be <4 mg/dL in SIADH (positive predictive value 73-100%) 1, 6
- Fractional excretion of urate (FEurate) - can improve diagnostic accuracy to 95% 1, 7
Treatment of SIADH
For asymptomatic or mild hyponatremia (Na 125-130 mEq/L), initiate fluid restriction to <1 L/day as first-line therapy; for severe symptomatic hyponatremia (Na <120 mEq/L) with altered mental status or seizures, administer 3% hypertonic saline immediately while treating the underlying cause. 1
Treatment Algorithm Based on Severity
Mild to Moderate Hyponatremia (Na 121-130 mEq/L, Asymptomatic)
First-line:
- Fluid restriction <1 L/day 1, 8
- Treat underlying cause - this is the definitive treatment 2, 5
- Monitor sodium every 4-6 hours initially
- High protein diet and oral sodium chloride 100 mEq TID if no response 6
Second-line options if fluid restriction fails:
- Demeclocycline 1
- Urea (40g in 100-150 mL normal saline every 8 hours) 6
- Vasopressin V2 receptor antagonists (tolvaptan, conivaptan) 1, 3
Severe Symptomatic Hyponatremia (Na <120 mEq/L with symptoms)
Immediate management:
- 3% hypertonic saline IV 1, 6
- Calculate sodium deficit: Desired increase in Na (mEq) × (0.5 × ideal body weight in kg) 6
- Correction targets:
Monitoring:
- Check sodium every 2 hours during acute correction 6
- Transfer to ICU for severe cases 6
- Consider desmopressin (DDAVP) clamp to prevent overcorrection from aquaresis 7
Adjunctive Therapies
- Vasopressin receptor antagonists (vaptans):
Critical Pitfalls to Avoid
Do NOT fluid restrict if patient has subarachnoid hemorrhage at risk for vasospasm - this increases cerebral infarction risk 6
Do NOT correct sodium faster than 8-10 mEq/L per 24 hours - risk of central pontine myelinolysis/osmotic demyelination syndrome 10, 6, 9, 8
Do NOT assume SIADH without excluding:
- Hypothyroidism
- Adrenal insufficiency
- Medication effects
- Cerebral salt wasting (if neurosurgical patient)
Do NOT use fluid restriction alone in severe symptomatic cases - hypertonic saline is required 1, 6
Do NOT ignore the underlying cause - treating only the sodium without addressing etiology (especially malignancy) leads to recurrence and poor outcomes 1, 2, 5
Special Considerations
If urine sodium remains very high (>130 mmol/L): This predicts poor response to fluid restriction and may require more aggressive therapy with vaptans or hypertonic saline 11
Chronic vs. acute hyponatremia: Your patient's chronicity matters - chronic cases (>48 hours) require slower, more cautious correction to avoid demyelination, while acute symptomatic cases require urgent correction 12, 7